Diclofenac: Nursing Drug Guide, GI Bleeding & Renal Risk & NCLEX Review

Diclofenac appears as Voltaren / Voltarol (oral delayed-release tablets 25 mg, 50 mg, 75 mg; topical gel), Cataflam (diclofenac potassium immediate-release tablets), and diclofenac epolamine transdermal patches. Verify the MAR and home list—patients may say “Voltaren gel” while inpatient orders list oral diclofenac sodium.

Do not confuse diclofenac with other NSAIDs (ibuprofen, naproxen, meloxicam, or celecoxib) when reconciling therapy. Duplicate NSAID exposure—including oral plus topical—dramatically increases GI bleeding and renal risk per NSAID class labeling.

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase, reducing prostaglandin-mediated pain and inflammation. It is used for arthritis and musculoskeletal pain when NSAID benefits outweigh cardiovascular, GI, and renal risks. Nurses administer oral tablets, topical gel, patches, and (in some settings) ophthalmic formulations—each route has different absorption and counseling needs.

↔On a small screen, swipe or scroll sideways to see the full table.

Diclofenac inhibits cyclooxygenase enzymes, decreasing prostaglandin synthesis involved in pain, fever, and inflammation. Like other NSAIDs, it carries a boxed warning for serious cardiovascular thrombotic events and serious GI bleeding. Diclofenac is metabolized primarily via CYP2C9 (and oxidation via CYP2C8 and CYP3A4 for minor metabolites); patients with hepatic impairment may need reduced doses because hepatic metabolism accounts for almost all elimination.

Use the lowest effective dose for the shortest duration consistent with treatment goals. Verify indication, hepatic and renal function, CYP2C9 metabolizer status, and concurrent anticoagulant or diuretic therapy before administration.

Renal impairment: Dosing adjustment is not necessary in mild to moderate renal dysfunction per pharmacokinetic studies, but avoid use in advanced renal disease unless benefits outweigh risk of worsening renal function. Correct dehydration before starting therapy.

Missed dose: If a scheduled dose is missed, give when remembered unless the next dose is due soon—do not double doses. For PRN acute pain regimens, do not exceed daily maximum per prescriber order and labeling.

↔On a small screen, swipe or scroll sideways to see the full table.

Pretreatment checks

• Perform medication reconciliation—screen for duplicate NSAIDs, aspirin, anticoagulants, ACE inhibitors, ARBs, and diuretics
• Review allergy history: diclofenac, aspirin/NSAID reactions, aspirin-sensitive asthma, prior serious NSAID skin reactions
• Assess cardiovascular history, blood pressure, edema, renal function (BUN/creatinine), and prior GI bleeding or peptic ulcer disease
• Confirm surgical plan—hold per protocol before CABG; NSAIDs are contraindicated for CABG pain

Contraindications

• Known hypersensitivity to diclofenac or any formulation excipient
• History of asthma, urticaria, or allergic-type reactions after aspirin or other NSAIDs
• Use in the setting of coronary artery bypass graft (CABG) surgery
• Prior serious skin reactions to NSAIDs (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) per labeling warnings

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Oral delayed-release tablets: Swallow whole; do not crush or chew unless pharmacy verifies an alternate administration method. May take with food or milk if GI upset occurs (supportive practice; verify with institutional policy).

Topical gel: Apply only to intact skin on the prescribed joint; use measured dosing per product label; wash hands after application and avoid contact with eyes. Prevent oral plus topical duplicate NSAID exposure unless the prescriber documents intent.

• Confirm home Voltaren gel, OTC NSAIDs, and herbal antiplatelet supplements are documented on the allergy/ home-med list after reconciliation
• Document indication, dose, route, time, and pain score before and after PRN doses
• Ensure fall-risk precautions in older adults with orthostatic symptoms or sedating co-medications

• Improved pain score or joint stiffness with functional mobility gains in arthritis
• Reduced swelling and tenderness on joint exam when inflammation is present
• No new GI bleeding, blood pressure elevation, edema, or renal function decline while therapy continues

Hold diclofenac and escalate immediately when serious NSAID complications are suspected.

• Black stool, hematemesis, coffee-ground emesis, or severe abdominal pain suggesting GI bleeding
• Chest pain, sudden weakness, facial droop, slurred speech, or other stroke or MI symptoms
• New or worsening dyspnea, rapid weight gain, or peripheral edema in patients with heart failure
• Decreased urine output, rising creatinine, or hyperkalemia suggesting acute kidney injury
• Urticaria, facial swelling, wheezing, or anaphylaxis after a dose
• Jaundice, dark urine, or persistent nausea with rising AST/ALT on liver function tests

↔On a small screen, swipe or scroll sideways to see the full table.

Symptoms following acute NSAID overdosage are typically limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding has occurred. Hypertension, acute renal failure, respiratory depression, and coma have occurred but were rare per diclofenac sodium delayed-release tablet labeling.

Management

• No specific antidote—provide symptomatic and supportive care
• Consider emesis and/or activated charcoal (60–100 g in adults) for symptomatic patients seen within four hours of ingestion or after large overdose per labeling
• Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion may not be useful due to high protein binding

• Diclofenac vs diflunisal—similar “-fenac/-lunisal” sound-alikes in verbal and phone orders; read back generic and strength
• Oral vs topical mix-ups—Voltaren gel on the skin is not interchangeable with oral milligram doses; teach patients not to “double up” routes
• Duplicate NSAID therapy—scheduled oral diclofenac plus PRN ibuprofen, naproxen, or ketorolac is a common inpatient error
• Strength errors—confirm 25 mg, 50 mg, or 75 mg delayed-release tablets; potassium salt products may differ in strength and frequency
• Potassium chloride confusion—do not confuse high-alert IV potassium orders with “potassium” diclofenac salt names in handoffs

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Pain and function using structured pain assessment and mobility goals
• GI status—stool color, hemoglobin trend, and symptoms of bleeding or ulcer
• Blood pressure, weight, edema, and heart failure symptoms
• Renal function and electrolytes on BMP when diuretics, ACE inhibitors, or ARBs are co-administered
• INR and bleeding signs when anticoagulants are used
• LFTs when hepatic risk factors or symptoms are present

Document

• Dose, route, time, indication, and pain score response for PRN doses
• Allergy verification (NSAID, aspirin-sensitive asthma, prior serious skin reaction)
• Patient education on bleeding, cardiovascular symptoms, and when to seek urgent care
• Hold parameters communicated to patient and on the MAR per institutional policy

• Take exactly as prescribed—do not combine with other ibuprofen, naproxen, or aspirin products unless your prescriber directs you to
• Report black or bloody stools, vomiting blood, severe stomach pain, chest pain, shortness of breath, sudden weakness, facial swelling, or rash immediately
• NSAIDs can raise blood pressure and cause swelling—report rapid weight gain or ankle swelling
• Tell all clinicians you take diclofenac before surgery, dental procedures, or new prescriptions
• If you use topical gel, wash hands after application and keep the medicated area away from infants’ skin and eyes
• Pregnancy planning: discuss risks with your prescriber—avoid late-pregnancy use per labeling

Do not give and contact the prescriber/pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Rehearse NCLEX-style clinical judgment practice for diclofenac using a tabbed inpatient case (MAR, labs, vitals, nursing notes), then priority action, cue recognition, trend interpretation, ordered escalation steps, pre-administration cloze, and matrix urgency sorting—recognise cues → analyse → prioritise → act → evaluate outcomes.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.